Summit Therapeutics
SMMT
#2224
Rank
โ‚น784.66 B
Marketcap
โ‚น981.12
Share price
-1.59%
Change (1 day)
-34.09%
Change (1 year)

Earnings for Summit Therapeutics (SMMT)

Earnings in 2026 (TTM): -โ‚น77.85 Billion

According to Summit Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น100.88 Billion a decrease over its 2024 earnings that were of -โ‚น20.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Summit Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น77.85 Billion-22.83%
2025 -โ‚น100.88 Billion387.84%
2024 -โ‚น20.68 Billion-64.01%
2023 -โ‚น57.46 Billion680.54%
2022 -โ‚น7.37 Billion-11.08%
2021 -โ‚น8.28 Billion67.46%
2020 -โ‚น4.95 Billion29.71%
2019 -โ‚น3.82 Billion
2014 -โ‚น2.99 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚น12.24 Billion-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.22 Billion-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-โ‚น14.21 Billion-81.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚น58.58 Billion-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA